Study guide
12.1 Nephron Transport & Renal Physiology
NBME Comprehensive Basic Science Examination CBSE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Navigation
1.1 Current Exam Facts & Administration 1.2 Content Blueprint & Physician Tasks 1.3 Scoring, Score Reports & Step 1 Readiness
2 Human Development
2.1 Embryology & Congenital Development Patterns 2.2 Normal Age-Related Findings & Well-Patient Care
3 Blood & Hematologic Disease
3.1 Hematopoiesis, RBC Disorders & Anemias 3.2 Hemostasis, Thrombosis & Coagulopathies 3.3 WBC Disorders, Leukemia & Lymphoma Mechanisms
4 Immune System
4.1 Innate & Adaptive Immunity Mechanisms 4.2 Hypersensitivity, Autoimmunity & Immunodeficiency 4.3 Transplant Immunology & Immune Pharmacology
5 Nervous System Anatomy & Disease
5.1 Neuroanatomy Localization & Pathways 5.2 Stroke, Infection, Demyelination & Trauma 5.3 Seizures, Movement Disorders & Neurodegeneration 5.4 Special Senses: Eye & Ear Mechanisms
6 Behavioral Health
6.1 Psychiatric Disorders & Diagnostic Patterns 6.2 Psychopharmacology Mechanisms 6.3 Neurotransmitters, Learning & Behavioral Science
7 Musculoskeletal System
7.1 Bone Physiology, Fracture Healing & Bone Pathology 7.2 Joint Disease, Rheumatology & Connective Tissue 7.3 Muscle, NMJ & Peripheral Nerve Disorders
8 Skin & Soft Tissue
8.1 Dermatopathology High-Yield Lesions 8.2 Inflammation, Wound Healing & Soft-Tissue Infection
9 Cardiovascular Pathophysiology
9.1 Cardiac Cycle, Hemodynamics & Murmurs 9.2 Ischemic Heart Disease & Cardiomyopathy 9.3 Congenital & Valvular Heart Disease 9.4 Vascular Pathology & Hypertension
10 Cardiovascular Pharmacology
10.1 Antihypertensives, Heart Failure & Antiarrhythmics 10.2 Antiplatelets, Anticoagulants & Lipid Drugs
11 Respiratory System
11.1 Pulmonary Mechanics & Gas Exchange 11.2 Obstructive, Restrictive & Vascular Lung Disease 11.3 Pulmonary Infections, Neoplasms & Respiratory Pharmacology
12 Renal Physiology & Electrolytes
12.1 Nephron Transport & Renal Physiology 12.2 Electrolyte Disorders 12.3 Acid-Base Physiology & Compensation
13 Renal Pathology
13.1 Glomerular Disease Mechanisms 13.2 Tubulointerstitial, Vascular & Stone Disease
14 Gastrointestinal System
14.1 GI Physiology, Motility & Digestion 14.2 Esophagus, Stomach & Intestinal Pathology 14.3 Liver, Biliary Tree & Pancreas 14.4 GI Microbiology, Nutrition & Malabsorption
15 Endocrine System
15.1 Hormone Signaling & Hypothalamic-Pituitary Axes 15.2 Thyroid & Parathyroid Disease 15.3 Adrenal Disorders & Steroid Pharmacology 15.4 Diabetes, Glucose Homeostasis & Metabolic Syndrome
16 Reproductive System
16.1 Male & Female Reproductive Physiology 16.2 Pregnancy, Placenta & Developmental Toxicology 16.3 Reproductive Pathology & Hormone-Related Neoplasia
17 Multisystem Processes & Disorders
17.1 Cell Injury, Inflammation & Repair 17.2 Neoplasia Principles & Tumor Biology 17.3 Infection, Sepsis & Multisystem Microbial Disease 17.4 Genetics, Inborn Errors & Environmental Toxicology
18 Biostatistics & Epidemiology
18.1 Study Design, Bias & Causation 18.2 Diagnostic Test Metrics & Screening 18.3 Epidemiology Measures & Population Health
19 Social Sciences & Communication
19.1 Ethics Principles & Decision-Making Capacity 19.2 Communication Skills & Difficult Conversations 19.3 Professionalism, Systems & Practice-Based Learning
20 Integrated Disciplines Capstone
20.1 High-Yield Microbiology Anchors Across Systems 20.2 High-Yield Biochemistry & Molecular Mechanisms 20.3 Integrated Pharmacology Strategy & Exam-Day Execution
12.1 Nephron Transport & Renal Physiology
Key Takeaways Explain This Topic AI
Proximal tubule reabsorbs ~65–70% of filtered Na+ via NHE3 and basolateral Na/K-ATPase; thick ascending limb uses NKCC2 (loop diuretic site); DCT uses NCC (thiazide site); CD principal cells use ENaC (amiloride/Liddle site).
GFR is determined by net filtration pressure and Kf; filtration fraction ≈ GFR/RPF (~0.20); clearance of PAH approximates RPF and inulin/creatinine approximate GFR.
RAAS raises angiotensin II (efferent constriction, ↑ FF, aldosterone, ADH stimulus) while ANP/BNP promote natriuresis and lower renin–aldosterone drive.
ADH inserts aquaporin-2 in collecting-duct principal cells; the countercurrent multiplier (NKCC2) and vasa recta exchanger create and preserve medullary hypertonicity for free-water reabsorption.
Free-water clearance (CH2O) is positive in dilute urine (water excretion) and negative when urine is concentrated under ADH (free-water reabsorption).
Last updated: August 2026
12.1 Nephron Transport & Renal Physiology
Quick Answer: Map Na+ transport by segment—NHE3 (PCT), NKCC2 (TAL), NCC (DCT), ENaC (CD)—with basolateral Na/K-ATPase powering all. GFR depends on net filtration pressure and Kf; filtration fraction ≈ GFR/RPF (~20%). RAAS defends volume; ADH inserts AQP2 for free-water reabsorption; ANP opposes volume overload. The countercurrent multiplier creates medullary hypertonicity that ADH uses to concentrate urine.
Renal physiology on the CBSE is tested as integrated mechanism: which transporter, which vessel tone change, which hormone, and what happens to volume, osmolality, or acid–base. Build one nephron map, then hang clearance math and endocrine loops on it.
Nephron Architecture and Filtration Barriers
Each kidney contains roughly 1 million nephrons . Blood enters the glomerulus via the afferent arteriole , filters across the glomerular capillary, and exits via the efferent arteriole . The filtrate then traverses the proximal convoluted tubule (PCT) , loop of Henle (thin descending, thin ascending, thick ascending limb [TAL]), distal convoluted tubule (DCT) , and collecting duct (CD) systems (cortical then medullary).
The filtration barrier has three layers: fenestrated endothelium, glomerular basement membrane (negatively charged), and podocyte slit diaphragms. Size and charge selectivity normally keep albumin and cells out of the filtrate. Damage to charge or podocyte architecture produces proteinuria—pathology that is tested more in later renal pathology sections, but the barrier concept frames what “filtered load” means for solutes.
Filtered load of substance X = GFR × Pₓ (plasma concentration of X, corrected for protein binding when relevant).
Segment-by-Segment Transporters (High-Yield Map)
Basolateral Na+/K+-ATPase (3 Na+ out / 2 K+ in) creates the low intracellular Na+ that drives apical secondary active transport in every segment that reabsorbs Na+.
Segment Key apical transporter(s) Major reabsorbate / function Classic blocker or lesion
PCT NHE3 (Na+/H+ exchanger), Na+–glucose (SGLT2/SGLT1), Na+–amino acid, Na+–phosphate (NPT2a) ~ 65–70% Na+/H2O; most HCO3− (via CA + NHE3); glucose, AA, PO4 CA inhibitors (acetazolamide); SGLT2i; Fanconi → global PCT loss
- Thin descending limb Aquaporins; passive water out Concentrates tubular fluid —
- Thin ascending limb Passive NaCl out (impermeable to water) Dilutes tubular fluid —
TAL (thick ascending) NKCC2 (Na-K-2Cl); ROMK recycles K+ ~ 20–25% Na+; diluting segment; generates medullary gradient Loop diuretics (furosemide); Bartter
DCT NCC (Na-Cl cotransporter) ~ 5–10% Na+; fine Ca2+ reabsorption via TRPV5 (thiazides ↑ Ca reabsorb) Thiazides ; Gitelman
CD principal cell ENaC (Na+ in); ROMK (K+ out) Fine Na+ reabsorption; K+ secretion Amiloride/triamterene; Liddle (↑ ENaC); aldosterone ↑ ENaC/Na/K-ATPase
CD intercalated cell H+-ATPase, H+/K+-ATPase; pendrin (Cl−/HCO3−) Acid–base fine-tuning RTA mechanisms (see 12.3)
Clinical pearl for exams: Loop diuretics act on NKCC2 (same site as Bartter). Thiazides act on NCC (same site as Gitelman). Amiloride blocks ENaC (opposite of Liddle gain-of-function). Always pair transporter ↔ drug ↔ genetic “diuretic-like” syndrome.
PCT also reabsorbs the bulk of filtered bicarbonate: luminal carbonic anhydrase and intracellular CA regenerate CO2/H2O and HCO3− that exits basolaterally via NBCe1. Blocking CA with acetazolamide causes HCO3− loss and mild metabolic acidosis with diuresis of NaHCO3.
GFR Determinants
Glomerular filtration rate (GFR) is the volume of plasma filtered per unit time (normal ~ 90–120 mL/min/1.73 m2 in young adults; often taught as ~ 125 mL/min in classic physiology problems). G F R = K f × net filtration pressure \mathrm{GFR} = K_f \times \text{net filtration pressure} GFR = K f × net filtration pressure
Net filtration pressure ≈ PGC − PBS − πGC , where:
- PGC = glomerular capillary hydrostatic pressure (favors filtration)
- PBS = Bowman space hydrostatic pressure (opposes filtration)
πGC = glomerular capillary oncotic pressure (opposes filtration; rises along the capillary as protein concentrates)
Kf (ultrafiltration coefficient) reflects surface area and hydraulic conductivity of the filtration barrier. Mesangial contraction or scarring lowers Kf and can lower GFR without a change in systemic pressure.
Afferent vs Efferent Tone (Exam Pattern)
- Change PGC / GFR tendency RPF tendency Filtration fraction (FF)
- Afferent constriction (e.g., high-dose NSAID effect on PGE) ↓ GFR ↓ RPF ~unchanged or ↓
- Efferent constriction (Ang II preferential) Maintains/↑ GFR relative to RPF ↓ RPF ↑ FF
- Afferent dilation (prostaglandins) Supports GFR ↑ RPF often ↓ or stable
- Combined low volume + ACEI/ARB (↓ Ang II) Can ↓ GFR sharply if GFR was Ang II–dependent variable ↓ FF pattern
Angiotensin II preferentially constricts the efferent arteriole, raising filtration fraction and helping preserve GFR when renal perfusion is low. Prostaglandins dilate the afferent arteriole. That is why NSAIDs (↓ PGE) plus ACE inhibitors/ARBs (↓ Ang II effect) are a classic setup for acute GFR drop in low effective arterial blood volume.
- Clearance Concepts and Filtration Fraction
- Renal clearance of X: C x = U x × V P x C_x = \frac{U_x \times V}{P_x} C x = P x U x × V
where Uₓ is urine concentration, V is urine flow rate, and Pₓ is plasma concentration.
- Marker / substance Clearance approximates Why
- Inulin GFR Freely filtered; neither reabsorbed nor secreted
- Creatinine GFR (slight overestimate) Freely filtered + small secretion
- PAH (low levels) Effective RPF Nearly completely extracted in one pass (filtered + secreted)
- Glucose (normal plasma) ~0 Completely reabsorbed until Tm exceeded
- Urea < GFR Partially reabsorbed
Filtration fraction (FF) = GFR / RPF . Normal FF is about 0.15–0.20 (often memorized as ~20% ). If GFR is 125 mL/min and RPF is 625 mL/min, FF = 0.20. Rising FF (efferent constriction, volume depletion with Ang II) increases peritubular oncotic pressure and favors proximal reabsorption—linking hemodynamics to Na+ retention.
Renal blood flow (RBF) ≈ RPF / (1 − Hct). Autoregulation keeps RBF and GFR relatively stable across mean arterial pressures roughly 80–180 mmHg via:
Myogenic response — afferent smooth muscle contracts when stretched by higher pressure.
Tubuloglomerular feedback (TGF) — macula densa senses increased NaCl delivery (via NKCC2), signals afferent constriction (adenosine/ATP pathways), lowering GFR back toward set point.
Outside the autoregulatory range, GFR falls with hypotension and can rise with severe hypertension until secondary injury intervenes.
RAAS Cascade
Juxtaglomerular cells release renin when they sense low perfusion pressure, increased sympathetic (β1) tone, or decreased NaCl delivery to the macula densa.
- Step Molecule Key actions
- 1 Renin Cleaves angiotensinogen → Ang I
- 2 ACE (lung endothelium) Ang I → Ang II ; also degrades bradykinin
3 Ang II Efferent > afferent constriction; ↑ FF; stimulates thirst, ADH release, aldosterone; direct proximal Na+ reabsorption; systemic vasoconstriction
4 Aldosterone ↑ ENaC and Na/K-ATPase in principal cells → Na+ retention, K+ and H+ secretion
ACE inhibitors block Ang II formation and raise bradykinin (cough/angioedema risk). ARBs block AT1 receptors. Both reduce aldosterone drive and can raise serum K+.
ADH, Aquaporins, and ANP
Antidiuretic hormone (ADH, vasopressin) is released from the posterior pituitary when plasma osmolality rises (dominant day-to-day stimulus via osmoreceptors) or when effective arterial volume falls markedly (baroreceptor override).
In principal cells of the collecting duct, V2 receptor → Gs–cAMP → trafficking of aquaporin-2 (AQP2) to the apical membrane. Water is reabsorbed down the medullary osmotic gradient. Basolateral AQP3/AQP4 provide exit pathways. Without ADH (central DI) or without response (nephrogenic DI), large volumes of dilute urine are excreted.
Atrial (and B-type) natriuretic peptide rises with atrial/ventricular stretch (volume overload). ANP/BNP increase GFR slightly (afferent dilation/efferent constriction pattern), inhibit renin and aldosterone, and promote natriuresis—opposing RAAS. Exam items often contrast RAAS (volume down) vs ANP (volume up).
Countercurrent Multiplier and Exchanger
Multiplier (loop of Henle): Active salt reabsorption by NKCC2 in the water-impermeable TAL adds solute to the medullary interstitium. The thin descending limb loses water to the hypertonic interstitium, so fluid at the tip of the long loop becomes highly concentrated. Fluid ascending the TAL becomes progressively dilute (“diluting segment”), enabling excretion of free water when ADH is low.
Exchanger (vasa recta): Medullary blood flow is arranged so solute is not washed out: descending vasa recta pick up solute and lose water; ascending vasa recta reverse the process. Slow medullary blood flow preserves the gradient. High medullary flow (e.g., osmotic diuresis states) can dissipate the gradient and impair concentrating ability.
Urea recycling under ADH (UT-A1 in inner medullary CD) contributes substantially to deep medullary osmolality—another reason low-protein states can mildly impair maximal concentration.
Typical corticomedullary gradient teaching numbers: cortex ~ 300 mOsm/kg , inner medulla up to ~ 1200–1400 mOsm/kg in humans under maximal ADH.
Free-Water Clearance Concepts
Osmolar clearance Cosm = (Uosm × V) / Posm.
Free-water clearance : C H 2 O = V − C o s m C_{H_2O} = V - C_{osm} C H 2 O = V − C os m
- State Uosm vs Posm CH2O Interpretation
- Water diuresis (no ADH) Uosm << Posm Positive Kidneys excrete electrolyte-free water
- Antidiuresis (ADH on) Uosm >> Posm Negative (TᶜH2O positive) Kidneys reabsorb free water
- Isosmotic urine Uosm ≈ Posm ~0 No free-water excretion or reabsorption
Exam logic: inability to generate positive CH2O means inability to dilute (e.g., loop diuretic blocking the diluting segment, or SIADH inappropriately concentrating). Inability to generate negative CH2O means inability to concentrate (DI, washout of gradient).
Putting It Together for CBSE Items
When a vignette gives volume depletion, predict ↑ renin → ↑ Ang II → ↑ aldosterone → Na+ retention, K+/H+ wasting risk, ↑ FF, and ADH release if osmolality or baroreceptors demand it. When a vignette gives a diuretic, name the transporter and the expected urinary electrolytes and acid–base pattern. When asked about concentrating ability, invoke NKCC2-dependent gradient + AQP2. When asked about “which clearance,” match inulin/creatinine to GFR and PAH to RPF, then compute FF as their ratio.
Master this map before electrolyte disorders and acid–base: those chapters assume you already know where Na+, K+, water, and H+ are handled along the nephron.